DekaBank Deutsche Girozentrale’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10K | Hold |
700
| – | – | ﹤0.01% | 1092 |
|
|
2025
Q4 | $56K | Hold |
700
| – | – | ﹤0.01% | 1317 |
|
|
2025
Q3 | $10K | Hold |
700
| – | – | ﹤0.01% | 1377 |
|
|
2025
Q2 | $10K | Hold |
700
| – | – | ﹤0.01% | 1384 |
|
|
2025
Q1 | $9K | Hold |
700
| – | – | ﹤0.01% | 1388 |
|
|
2024
Q4 | $11K | Sell |
700
-2,800
| -80% | -$42.1K | ﹤0.01% | 1406 |
|
|
2024
Q3 | $55K | Hold |
3,500
| – | – | ﹤0.01% | 1349 |
|
|
2024
Q2 | $52K | Hold |
3,500
| – | – | ﹤0.01% | 1381 |
|
|
2024
Q1 | $50K | Hold |
3,500
| – | – | ﹤0.01% | 1359 |
|
|
2023
Q4 | $48K | Hold |
3,500
| – | – | ﹤0.01% | 1405 |
|
|
2023
Q3 | $46K | Hold |
3,500
| – | – | ﹤0.01% | 1405 |
|
|
2023
Q2 | $44K | Hold |
3,500
| – | – | ﹤0.01% | 1231 |
|
|
2023
Q1 | $39K | Hold |
3,500
| – | – | ﹤0.01% | 1279 |
|
|
2022
Q4 | $36K | Hold |
3,500
| – | – | ﹤0.01% | 1313 |
|
|
2022
Q3 | $36K | Hold |
3,500
| – | – | ﹤0.01% | 1334 |
|
|
2022
Q2 | $38K | Hold |
3,500
| – | – | ﹤0.01% | 1326 |
|
|
2022
Q1 | $39K | Hold |
3,500
| – | – | ﹤0.01% | 1297 |
|
|
2021
Q4 | $45K | Hold |
3,500
| – | – | ﹤0.01% | 1373 |
|
|
2021
Q3 | $45K | Hold |
3,500
| – | – | ﹤0.01% | 1334 |
|
|
2021
Q2 | $52K | Buy |
+3,500
| New | +$48.9K | ﹤0.01% | 1345 |
|
|
2018
Q1 | – | Sell |
-28,800
| Closed | -$178K | – | 1203 |
|
|
2017
Q4 | $178K | Hold |
28,800
| – | – | ﹤0.01% | 949 |
|
|
2017
Q3 | $178K | Hold |
28,800
| – | – | ﹤0.01% | 955 |
|
|
2017
Q2 | $237K | Buy |
+28,800
| New | +$234K | ﹤0.01% | 918 |
|
|
2016
Q1 | – | Sell |
-42,500
| Closed | -$393K | – | 1092 |
|
|
2015
Q4 | $393K | Buy |
42,500
+7,500
| +21% | +$82.1K | ﹤0.01% | 735 |
|
|
2015
Q3 | $447K | Buy |
35,000
+30,000
| +600% | +$373K | 0.01% | 715 |
|
|
2015
Q2 | $55K | Sell |
5,000
-83,000
| -94% | -$916K | ﹤0.01% | 1071 |
|
|
2015
Q1 | $1M | Buy |
88,000
+80,000
| +1,000% | +$849K | 0.01% | 574 |
|
|
2014
Q4 | $80K | Buy |
+8,000
| New | +$84.2K | ﹤0.01% | 953 |
|
|
2014
Q2 | – | Sell |
-95,000
| Closed | -$834K | – | 987 |
|
|
2014
Q1 | $834K | Buy |
95,000
+2,500
| +3% | +$21.7K | 0.01% | 500 |
|
|
2013
Q4 | $757K | Buy |
92,500
+18,000
| +24% | +$142K | 0.01% | 485 |
|
|
2013
Q3 | $563K | Buy |
74,500
+7,000
| +10% | +$50.9K | 0.01% | 531 |
|
|
2013
Q2 | $495K | Buy |
+67,500
| New | +$493K | 0.01% | 451 |
|
Other funds holding RDY
AIM
DekaBank Deutsche Girozentrale's RDY Position: Q1 2026 in Review
DekaBank Deutsche Girozentrale held its Dr. Reddy's Laboratories (RDY) position steady in Q1 2026 at 700 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #1092.
DekaBank Deutsche Girozentrale first reported a position in RDY in Q2 2013 and has held it in 32 quarters since. The position peaked at $1M in Q1 2015. 247 funds tracked by Wall St. Rank hold RDY as of Q1 2026.
- DekaBank Deutsche Girozentrale held 700 shares of Dr. Reddy's Laboratories worth $10K as of Q1 2026.
- DekaBank Deutsche Girozentrale left its Dr. Reddy's Laboratories share count unchanged in Q1 2026.
- Dr. Reddy's Laboratories made up ﹤0.01% of DekaBank Deutsche Girozentrale's portfolio in Q1 2026, its #1092 holding.
- DekaBank Deutsche Girozentrale first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 32 quarters since.
- DekaBank Deutsche Girozentrale's Dr. Reddy's Laboratories position peaked at $1M in Q1 2015.
- 247 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.